Company Filing History:
Years Active: 1994
Title: Youko Mitani: Innovator in Pharmaceutical Formulations
Introduction
Youko Mitani is a notable inventor based in Suita, Japan. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of prolonged-release liquid preparations. With a total of 2 patents, her work has the potential to enhance the stability and effectiveness of pharmaceutical products.
Latest Patents
Youko Mitani's latest patents include a "Prolonged-release liquid type of pharmaceutical preparation" and a "Pharmaceutical formulation in the form of aqueous suspension." The first patent describes a formulation that provides a prolonged-release liquid type of pharmaceutical preparation. This preparation is created by coating a pharmaceutically active drug-ion exchange resin complex with a water-permeable diffusion barrier material. The formulation is designed to remain stable and maintain controlled release, even in solutions containing preservatives. The second patent focuses on an aqueous suspension that includes an ion exchange resin carrying an active ingredient and a suspending agent, enhanced by the addition of a basic or neutral amino acid or its salt as a dispersion stabilizer.
Career Highlights
Throughout her career, Youko Mitani has worked with prominent companies in the pharmaceutical industry, including Rohto Pharmaceutical Co., Ltd. Her expertise in pharmaceutical formulations has positioned her as a valuable asset in the development of innovative drug delivery systems.
Collaborations
Youko has collaborated with esteemed colleagues such as Mitsuo Umemoto and Kiyotsugu Higashi. These partnerships have contributed to her success and the advancement of her research in pharmaceutical sciences.
Conclusion
Youko Mitani's contributions to the field of pharmaceutical formulations demonstrate her innovative spirit and dedication to improving drug delivery systems. Her patents reflect a commitment to enhancing the stability and effectiveness of medications, ultimately benefiting patients worldwide.